Triangle Biotechnology, Inc.

Triangle Biotechnology, Inc. is a life science company that develops innovative sonication reagents designed to streamline biological sample preparation. The company's core technology, Amplified Acoustic Mechanical Processing (AAMP), utilizes patented nanodroplet-based reagents that, when added to a sample and subjected to ultrasound, act as microscopic mechanical amplifiers. These reagents store and release controlled cavitation energy, facilitating more efficient, high-throughput, and consistent processing compared to conventional methods. By enhancing the delivery of mechanical force directly to the sample, the technology enables high-quality extraction of DNA, chromatin, and other biomolecules, even from challenging materials like formalin-fixed paraffin-embedded (FFPE) tissues.

This technology directly addresses critical bottlenecks in next-generation sequencing (NGS), epigenetic assays, and clinical diagnostics, where sample preparation is often a slow, inconsistent, or expensive hurdle. By significantly increasing yields and processing speed while reducing required starting material, Triangle Biotechnology’s solutions enable researchers and clinicians to obtain high-quality data more reliably and cost-effectively. The company collaborates with researchers to apply these tools across various applications, including microbial enrichment for pathogen characterization and streamlined NGS workflows, helping to accelerate personalized medicine and therapeutic research.